Market closed
Champions Oncology/$CSBR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Champions Oncology
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Ticker
$CSBR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
-
Website
CSBR Metrics
BasicAdvanced
$108M
17.27
$0.46
0.20
-
Price and volume
Market cap
$108M
Beta
0.2
52-week high
$11.99
52-week low
$3.75
Average daily volume
37K
Financial strength
Current ratio
0.991
Quick ratio
0.955
Long term debt to equity
91.479
Total debt to equity
117.7
Interest coverage (TTM)
240.14%
Management effectiveness
Return on assets (TTM)
14.64%
Return on equity (TTM)
376.84%
Valuation
Price to earnings (TTM)
17.272
Price to revenue (TTM)
1.835
Price to book
19.8
Price to tangible book (TTM)
21.09
Price to free cash flow (TTM)
-75.131
Growth
Revenue change (TTM)
19.03%
Earnings per share change (TTM)
-163.20%
3-year revenue growth (CAGR)
7.78%
3-year earnings per share growth (CAGR)
272.83%
What the Analysts think about CSBR
Analyst Ratings
Majority rating from 1 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Champions Oncology stock?
Champions Oncology (CSBR) has a market cap of $108M as of April 27, 2025.
What is the P/E ratio for Champions Oncology stock?
The price to earnings (P/E) ratio for Champions Oncology (CSBR) stock is 17.27 as of April 27, 2025.
Does Champions Oncology stock pay dividends?
No, Champions Oncology (CSBR) stock does not pay dividends to its shareholders as of April 27, 2025.
When is the next Champions Oncology dividend payment date?
Champions Oncology (CSBR) stock does not pay dividends to its shareholders.
What is the beta indicator for Champions Oncology?
Champions Oncology (CSBR) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.